1-12 of 12
Matthew G. Mei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multi-Center Retrospective Analysis

Eleanor Taranto, Wei-Ting Hwang, Maria Alfaro, Annika S Surapaneni, Sarvarinder Kaur Gill, Tatyana Feldman, Michael P Randall, Michael A Spinner, Fateeha Furqan, Nirav N. Shah, Yazeed Samara, Matthew G. Mei, Alex F. Herrera, Alison Moskowitz, Gunjan L. Shah, Jakub Svoboda
Journal: Blood
Blood (2023) 142 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2023-187199
Published: 2023
Journal Articles

Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

Matthew G. Mei, Gaetano Corazzelli, Frank Morschhauser, Elizabeth Phillips, Graham P. Collins, Hun Ju Lee, Steve M Ansell, Craig H. Moskowitz, Nathalie A. Johnson, John Kuruvilla, Martin Hutchings, María José Terol Castera, George Hawkins, Anna Vossenkaemper, Teresa Collins, Robin Lesley, Emma Dean, Ting Yu, Connor Hall, Virginie Cerec, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2023-180926
Published: 2023
Journal Articles

Impact of Peri-Transplant Radiation on Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant

Kelsey Baron, Esther Drill, Nivetha Ganesan, Reid W. Merryman, Matthew G. Mei, Robert Stuver, Sanjal H. Desai, Ayo S Falade, Siddharth Iyengar, Ivana Micallef, Lay She Ng, Ellie Casper, Natasha Galasso, Randa Tao, Savita Dandapani, Andrea Ng, Joachim Yahalom, Alex F. Herrera, Alison Moskowitz, Harsh Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4436.
https://doi.org/10.1182/blood-2023-173470
Published: 2023
Journal Articles

The Combination of Nivolumab and CC-486 Is Active in Hodgkin Lymphoma Refractory to PD-1 Blockade

Matthew G. Mei, Lu Chen, Sandrine Puverel, L. Elizabeth Budde, Swetha Kambhampati, Shari Daniels, Bev Dunning, Melissa Banez, Larry W. Kwak, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (Supplement 1): 1697.
https://doi.org/10.1182/blood-2023-190753
Published: 2023
Journal Articles

Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies

Robert Stuver, Esther Drill, Nivetha Ganesan, Kelsey Baron, Ellie Casper, Tiffany Chang, Sanjal H. Desai, Ayo S Falade, Natasha Galasso, Alex F. Herrera, Matthew G. Mei, Reid W. Merryman, Ivana Micallef, Harsh Shah, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3069.
https://doi.org/10.1182/blood-2023-182143
Published: 2023
Journal Articles

Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Scott R. Goldsmith, Geoffrey P. Shouse, F. Lennie Wong, Alysia Bosworth, Aleksi Iujuridze, Sitong Chen, June-Wha Rhee, Matthew G. Mei, Murali Janakiram, Myo Htut, Stephen J. Forman, Raju Pillai, L. Elizabeth Budde, Saro Armenian
Journal: Blood
Blood (2023) 142 (Supplement 1): 4814.
https://doi.org/10.1182/blood-2023-185157
Published: 2023
Journal Articles

Trial-in-Progress: A Phase 1/2 Multi-Center Study of Onct-808, a ROR1-Specific CAR T, in Adult Patients with Relapsed/Refractory Aggressive B Cell Lymphoma

Michael L. Wang, Matthew J. Frigault, Salim Yazji, Yisrael Katz, James Robinson, James B. Breitmeyer, Matthew G. Mei, Caron A Jacobson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4857.
https://doi.org/10.1182/blood-2023-180989
Published: 2023
Journal Articles

Clonal Hematopoiesis Is Associated with Cardiovascular Disease Risk and Worse Survival after Autologous Hematopoietic Cell Transplantation for Lymphoma

June-Wha Rhee, Raju Pillai, Sitong Chen, Alysia Bosworth, Liezl Atencio, Artem Oganesyan, Kendall Freeman, Tati Guzman, Kara Lukas, Kelly Peng, Brianna Sigala, Aleksi Iujuridze, Lanie Lindenfeld, Faizi Jamal, Alex F. Herrera, Matthew G. Mei, Ryotaro Nakamura, F. Lennie Wong, Stephen J. Forman, Saro Armenian
Journal: Blood
Blood (2023) 142 (Supplement 1): 784.
https://doi.org/10.1182/blood-2023-177832
Published: 2023
Journal Articles

Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma

Clinical Trials & Observations
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, Lihua Elizabeth Budde, Matthew G. Mei, Tanya Siddiqi, Leslie L. Popplewell, Yi-Ping Wen, Jasmine Zain, Stephen J. Forman, Larry W. Kwak, Steven T. Rosen, Alexey V. Danilov, Alex F. Herrera, Nikhil R. Thiruvengadam
Journal: Blood
Blood (2022) 140 (25): 2697–2708.
https://doi.org/10.1182/blood.2022016624
Published: 2022
Includes: Supplemental data
Journal Articles

Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, Lihua Elizabeth Budde, Matthew G. Mei, Leslie L. Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen J. Forman, Larry W. Kwak, Steven T. Rosen, Alexey V. Danilov, Alex F. Herrera, Nikhil R. Thiruvengadam
Journal: Blood
Blood (2022) 140 (19): 2024–2036.
https://doi.org/10.1182/blood.2022016747
Published: 2022
Includes: Supplemental data
Journal Articles

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Clinical Trials & Observations
Matthew G. Mei, Hun Ju Lee, Joycelynne M. Palmer, Robert Chen, Ni-Chun Tsai, Lu Chen, Kathryn McBride, D. Lynne Smith, Ivana Melgar, Joo Y. Song, Kimberley-Jane Bonjoc, Saro Armenian, Mary Nwangwu, Peter P. Lee, Jasmine Zain, Liana Nikolaenko, Leslie Popplewell, Auayporn Nademanee, Ammar Chaudhry, Steven Rosen, Larry Kwak, Stephen J. Forman, Alex F. Herrera
Journal: Blood
Blood (2022) 139 (25): 3605–3616.
https://doi.org/10.1182/blood.2022015423
Published: 2022
Includes: Supplemental data
Journal Articles

Double Expressing (MYC/BCL2) and Double-Hit Diffuse Large B-Cell Lymphomas Have Inferior Survival Following Autologous Stem Cell Transplantation

Alex F. Herrera, MD, Matthew G. Mei, MD, Lawrence Low, MD PhD, Reid W. Merryman, MD, Joo Y. Song, MD, Tanya Paris, Tracey Stiller, Victoria Bedell, Heather Sun, Jennifer R. Brown, MD PhD, Lihua Elizabeth Budde, MD PhD, Robert Chen, Matthew S. Davids, MD, Arnold S. Freedman, MD, David C. Fisher, MD, Eric D. Jacobsen, MD, Caron A. Jacobson, MD, Haesook T. Kim, PhD, Ann S. LaCasce, MD, Joyce Murata-Collins, PhD, Auayporn P. Nademanee, MD, Joycelynne Palmer, PhD, German A. Pihan, MD, Tanya Siddiqi, MD, Aliyah R Sohani, MD, Leslie L. Popplewell, MD, Jasmine Zain, MD, Larry W. Kwak, MD, David M. Weinstock, Stephen J. Forman, MD, Dennis D. Weisenburger, MD, Young Kim, MD, Scott J. Rodig, MD, PhD, Amrita Krishnan, Philippe Armand, MD PhD
Journal: Blood
Blood (2015) 126 (23): 522.
https://doi.org/10.1182/blood.V126.23.522.522
Published: 2015